1. Home
  2. TROX vs MGTX Comparison

TROX vs MGTX Comparison

Compare TROX & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

N/A

Current Price

$3.84

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

N/A

Current Price

$10.64

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TROX
MGTX
Founded
2018
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
TROX
MGTX
Price
$3.84
$10.64
Analyst Decision
Hold
Buy
Analyst Count
8
8
Target Price
$6.75
★ $27.75
AVG Volume (30 Days)
★ 1.9M
815.0K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
★ 5.06%
N/A
EPS Growth
N/A
★ 33.02
EPS
N/A
★ 1.30
Revenue
★ $2,898,000,000.00
$81,391,000.00
Revenue This Year
$13.47
$314.19
Revenue Next Year
$4.54
N/A
P/E Ratio
★ N/A
$8.49
Revenue Growth
N/A
★ 144.57
52 Week Low
$2.86
$6.62
52 Week High
$10.59
$15.35

Technical Indicators

Market Signals
Indicator
TROX
MGTX
Relative Strength Index (RSI) 23.57 27.75
Support Level N/A $8.84
Resistance Level $4.53 $11.85
Average True Range (ATR) 0.18 0.57
MACD 0.00 -0.21
Stochastic Oscillator 1.35 8.33

Price Performance

Historical Comparison
TROX
MGTX

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: